ClinicalTrials.gg
Not yet recruitingNCT07264829Updated Aug 25, 2026

This Clinical Trial Aims to Compare the Effectiveness of Two Intra-pulpal Cryotherapy Techniques-Endo-ice and Ice Sticks-in Decreasing Intra-operative Pain and Enhancing the Success of Local Anesthesia During Pulpectomy of Mandibular Molars With Symptomatic Irreversible Pulpitis.

An interventional study of Endo-ice (Refrigerant Spray) and Ice-sticks in Root Canal Treatment, Intra-operative Pain and Symptomatic Irreversible Pulpitis, sponsored by Dow University of Health Sciences. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Dow University of Health Sciences · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trail is to compare the analgesic effect of endo-ice and ice-sticks in reducing intra-operative pain during pulpectomy in molars with Symptomatic Irreversible Pulpitis. Principal Investigator will perform the procedure and outcome assessor will interview the participants as well as fill the pre-operative questionnaire. The patient will be instructed beforehand on how to score their pre-operative, intra-operative and post-operative intensity of pain according to Visual Analogue Scale.The Anxiety level of patient will also be recorded according to the Corah's Dental Anxiety Scale questionnaire and their level of anxiety before and after the intervention will be recorded by the outcome assessor.

The principal investigator will perform all endodontic procedures, with the outcome assessor blinded to the cryotherapy method. Prior to administering IANB, a topical anesthetic gel will be applied. A 27-gauge needle will deliver 1.8 ml of 2% lidocaine with 1:100,000 epinephrine at a rate of 1 ml/min. After a 5-minute wait, anesthesia effectiveness will be confirmed through electric pulp testing (EPT) on a neighboring tooth, with two consecutive negative responses confirming success. Once adequate anesthesia is confirmed, an access opening will be made under rubber dam isolation for the procedure.

  1. CONTROL GROUP: After access opening and complete de-roofing of the pulp chamber, pulpectomy of the inflamed pulp will be performed under the given effective IANB with no additional intervention to control intra-operative pain.
  2. ENDO-ICE GROUP: After access opening, pulp will be exposed and de-roofing will be performed. Endo-ice with the help of cotton pellet will be applied inside the pulp chamber for 2min (8 consecutive applications, 15sec each) and pulpectomy of the inflammed pulp will be performed immediately.
  3. ICE-STICKS GROUP: Following the access opening and complete de-roofing of pulp chamber, four ice sticks will be placed inside the pulp chamber for 2 minutes (30 seconds each, using tweezer). Subsequently, pulpectomy of the inflamed pulp will be performed immediately.

Patients will be asked to rate their level of pain to the outcome assessor at four specific intervals during the trial, i.e., pre-operative (before local anesthesia), pre-operative (after local anesthesia), during pulpectomy and immediately after pulp extirpation and it will be recorded in a proforma by the blinded outcome assessor.

Pain and Anxiety Scores will be compared to asses either cryotherapy or which method of cryotherapy found to be effective in reducing intra-operative pain.

Read the detailed description

INTRODUCTION:

Acute pain associated with symptomatic irreversible pulpitis (SIP) can be induced by any stimuli or occur spontaneously and may persist for up to 30 seconds or beyond the removal of the stimulus, signaling the need for endodontic treatment. An essential prerequisite for successful endodontic therapy is effective pulpal anesthesia. The standard method for achieving regional anesthesia in mandibular molar involves an inferior alveolar nerve block (IANB) combined with buccal infiltration. However, an IANB does not always provide successful pulpal anesthesia, particularly in patients with symptomatic irreversible pulpitis (SIP).The occurrence of pain during endodontic treatment of teeth with SIP poses a significant challenge for both the clinician and the patient. In such circumstances, painless pulp extirpation becomes challenging. In endodontics, cryotherapy has been used following periradicular surgeries and as a final irrigant (cold saline) before obturation to reduce postoperative pain and inflammation.

METHODOLOGY:

This research will be conducted using a randomized controlled trial at Dow International Dental College. The target demographics includes 60 individuals with pain mandibular molars, experiencing moderate to severe pain (VAS 4-10), diagnosed with symptomatic irreversible pulpitis, planned for endodontic treatment. Pulpal sensibility will be assessed with cold test and electric pulp tester. Digital peri-apical x-rays will be used to evaluate the extent of caries and periapical status. Group allocation will be done by Computer generated random numbers. Individuals will be divided into 3 groups (20 each). 1. Control Group 2. Cryotherapy with endo-ice 3. Cryotherapy with ice-sticks. Cryotherapy methods (Endo-ice and Ice-sticks) will be used as an intervention to control per-operative pain in Intervention Groups and no additional measures will be taken to control pain in Control group, which is the standard method). After confirming the success of anesthesia, procedure will be started in all 3 groups.

The outcome assessor will interview the participants as well as fill the pre-operative questionnaire. The patient will be instructed beforehand on how to score their pre-operative, intra-operative and post-operative intensity of pain according to VAS. Similarly, for anxiety assessment, the patients will be interviewed according to the DAS-R questionnaire and their level of anxiety before and after the intervention will be recorded by the outcome assesor.

02

Conditions studied

  • Root Canal Treatment
  • Intra-operative Pain
  • Symptomatic Irreversible Pulpitis
  • Cryotherapy Effect

Browse trials for

Keywords

  • Cryotherapy
  • Endodontic treatment
  • Intra-operative pain
  • Pulpectomy
  • Endo-ice
  • Ice-sticks
  • Symptomatic Irreversible Pulpitis
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 90 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Dow University of Health Sciences is the lead sponsor of 179 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Individuals (Male and Female) aged 18 to 40 years.
  2. Healthy individuals with no significant present and past medical findings.
  3. Mandibular molars.
  4. Symptomatic irreversible pulpitis (moderate to severe pain according to VAS 4-10).
  5. Periapical index (PAI) Score: 1-3 on periapical radiograph.
  6. DAS-R: 4-14( mild to moderate anxiety)

Exclusion criteria

Exclusion Criteria:

  1. Immature teeth with open apices.
  2. Calcified pulp chamber and canals.
  3. Periodontally compromised teeth.
  4. Individuals who had taken , analgesics, or antibiotics within the last 48 hours.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Control Group

    The principal investigator will perform the endodontic procedure, with the outcome assessor blinded to the cryotherapy method. Prior to administering IANB, a topical anesthetic gel will be applied. A 27-gauge needle will deliver 1.8 ml of 2% lidocaine with 1:100,000 epinephrine at a rate of 1 ml/min. After a 5-minute wait, anesthesia effectiveness will be confirmed through electric pulp testing (EPT) on a neighboring tooth, with two consecutive negative responses confirming success. Once adequate anesthesia is confirmed, an access opening will be made under rubber dam isolation for the procedure. In Control Group, after access opening and complete de-roofing of the pulp chamber, pulpectomy of the inflamed pulp will be performed under the given effective Inferior alveolar nerve block with no additional intervention to control intra-operative pain.

  • Experimental
    Endo-ice Group

    The principal investigator will perform the endodontic procedure, with the outcome assessor blinded to the cryotherapy method. Prior to administering IANB, a topical anesthetic gel will be applied. A 27-gauge needle will deliver 1.8 ml of 2% lidocaine with 1:100,000 epinephrine at a rate of 1 ml/min. After a 5-minute wait, anesthesia effectiveness will be confirmed through electric pulp testing (EPT) on a neighboring tooth, with two consecutive negative responses confirming success. Once adequate anesthesia is confirmed, an access opening will be made under rubber dam isolation for the procedure. In Endo-ice Group, after access opening, pulp will be exposed and de-roofing will be performed. Endo-ice with the help of cotton pellet will be applied inside the pulp chamber for 2min (8 consecutive applications, 15sec each) and pulpectomy of the inflammed pulp will be performed immediately.

    Other: Endo-ice (Refrigerant Spray)

  • Experimental
    Ice-sticks Group

    The principal investigator will perform the endodontic procedure, with the outcome assessor blinded to the cryotherapy method. Prior to administering IANB, a topical anesthetic gel will be applied. A 27-gauge needle will deliver 1.8 ml of 2% lidocaine with 1:100,000 epinephrine at a rate of 1 ml/min. After a 5-minute wait, anesthesia effectiveness will be confirmed through electric pulp testing (EPT) on a neighboring tooth, with two consecutive negative responses confirming success. Once adequate anesthesia is confirmed, an access opening will be made under rubber dam isolation for the procedure. In Ice-sticks Group, following the access opening and complete de-roofing of pulp chamber, four ice sticks will be placed inside the pulp chamber for 2 minutes (30 seconds each, using tweezer). Subsequently, pulpectomy of the inflamed pulp will be performed immediately.

    Other: Ice-sticks

Interventions

  • OtherEndo-ice (Refrigerant Spray)

    Endo-ice (1,1, 1,2-Tetrafluoroethane, Refrigerant spray) have been most frequently used in dentistry to assess pulp sensibility. In this study, Endo-ice will be used to perform intra-coronal cryotherapy and its effectiveness in reducing intra-operative pain will be evaluated.

  • OtherIce-sticks

    Ice-sticks have been mostly used in dentistry to assess pulp sensibility. In this study, Ice-sticks will be used to perform intra-coronal cryotherapy and it's effectiveness in reducing intra-operative pain will be evaluated.

06

What researchers measure

Primary outcomes

  1. Measuring Intra-operative pain using Visual Analogue Scale

    Patient will be interviewed at different intervals during the procedure and pain scores will recorded with the help of Visual Analogue Scale. This scale usually features a 10 cm line from score 0 to 10 with well-defined boundaries, where 0 indicates No Pain and 7-10 indicates Severe Pain.

    Time frame: 3 hours

Secondary outcomes

  1. Measuring Anxiety during procedure using Corah's Dental Anxiety Scale

    Patient will be interviewed by the outcome assessor before and after the procedure and anxiety will be measured using Corah's Dental Anxiety Scale. It consists of four scenarios pertaining to dental treatment, each with five response options that reflects varying levels of anxiety. The total of these responses varies from 4 to 20, with scores above 12 indicate nervous patients and above 15 indicates phobic levels of anxiety.

    Time frame: 3 hours

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Nov 2026, 2 months later.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 24, 2025
First posted
Dec 4, 2025
StartEst.
Sep 15, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07264829
Responsible party
Tina Lohana (FCPS Resident, Dow University of Health Sciences) — Principal investigator
First posted
Dec 4, 2025
Start date
Sep 15, 2026 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Aug 25, 2026

Study contacts

Tina Lohana
Contact
tinalohana.2823579@duhs.edu.pk
+923028328589
Farah Naz, BDS, FCPS
study chair · Dow University of Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion